Editor's Comparative Analysis
When choosing between CHEST Pulmonary and COPD, researchers should consider the trade-off between prestige (COPD leads with an IF of ) and publication speed.
CHEST Pulmonary is published in US, while COPD is headquartered in GB. Both titles are verified via the JournalsHub Live Indexing Tracker for 2026.
| Academic Metric | CHEST Pulmonary | COPD |
|---|---|---|
| General Information | ||
| Publisher | Elsevier | Taylor & Francis Group |
| Country of Origin | US | GB |
| Established | 2024 | 2022 |
| Editor-in-Chief | See Website | See Website |
| Scientific Influence | ||
| Current Impact Factor | N/A | N/A |
| Indexing Status |
DOAJ
|
DOAJ
|
| Review Speed (Decision) |
83 days
Standard
|
24 days
Fast-Track
|
| Acceptance Rate | N/A | N/A |
| Access & Publication Fees | ||
| Open Access Type | Full OA | Full OA |
| APC Fee (Estimated) | $2,500.00 | $3,300.00 |
Historical Impact Factor Comparison
No historical impact factor data available for these journals yet.
About CHEST Pulmonary
CHEST Pulmonary is a prominent academic journal specializing in Diseases of the respiratory system. Published by Elsevier in US, the journal serves as an essential platform for researchers to share high-quality scholarly work. It is fully Open Access publication identified by ISSN 2949-7892. The journal aims to advance the boundaries …
View Full ProfileAbout COPD
COPD is a prominent academic journal specializing in Diseases of the respiratory system. Published by Taylor & Francis Group in GB, the journal serves as an essential platform for researchers to share high-quality scholarly work. It is fully Open Access publication identified by ISSN 1541-2555. The journal aims to advance …
View Full ProfileSearching for: CHEST Pulmonary impact factor, COPD APC fees, journal comparison tool 2026.